{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "https://eldaddp.azurewebsites.net/answeredquestions.text?date=2020-10-30&min-ddpModified.=2020-04-06T17%3A36%3A06.966Z", "definition" : "https://eldaddp.azurewebsites.net/meta/answeredquestions.text?date=2020-10-30&min-ddpModified.=2020-04-06T17%3A36%3A06.966Z", "extendedMetadataVersion" : "https://eldaddp.azurewebsites.net/answeredquestions.text?date=2020-10-30&_metadata=all&min-ddpModified.=2020-04-06T17%3A36%3A06.966Z", "first" : "https://eldaddp.azurewebsites.net/answeredquestions.text?date=2020-10-30&_page=0&min-ddpModified.=2020-04-06T17%3A36%3A06.966Z", "hasPart" : "https://eldaddp.azurewebsites.net/answeredquestions.text?date=2020-10-30&min-ddpModified.=2020-04-06T17%3A36%3A06.966Z", "isPartOf" : "https://eldaddp.azurewebsites.net/answeredquestions.text?date=2020-10-30&min-ddpModified.=2020-04-06T17%3A36%3A06.966Z", "items" : [{"_about" : "http://data.parliament.uk/resources/1247007", "AnsweringBody" : [{"_value" : "Treasury"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1247007/answer", "answerText" : {"_value" : "VAT is a broad-based tax on supplies of goods and services, and exceptions are limited and set out in legislation. High-factor sunscreen is on the NHS prescription list for certain conditions and qualifies for a VAT zero rate when prescribed and dispensed by a pharmacist.
<\/p>
Making all sunscreen VAT-free would come at a considerable cost to the Exchequer. While all taxes are kept under review, there are currently no plans to reduce VAT on sunscreen products.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/3991", "label" : {"_value" : "Biography information for Jesse Norman"} } , "answeringMemberConstituency" : {"_value" : "Hereford and South Herefordshire"} , "answeringMemberPrinted" : {"_value" : "Jesse Norman"} , "dateOfAnswer" : {"_value" : "2020-11-09", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2020-11-09T16:13:17.847Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "14"} , "answeringDeptShortName" : {"_value" : "Treasury"} , "answeringDeptSortName" : {"_value" : "Treasury"} , "date" : {"_value" : "2020-10-30", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Sunscreens: VAT"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Chancellor of the Exchequer, what assessment he has made of the potential merits of re-classifying sun cream from a cosmetic product to an essential product for the purposes of VAT.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4757", "label" : {"_value" : "Biography information for Shaun Bailey"} } , "tablingMemberConstituency" : {"_value" : "West Bromwich West"} , "tablingMemberPrinted" : [{"_value" : "Shaun Bailey"} ], "uin" : "109669"} , {"_about" : "http://data.parliament.uk/resources/1247008", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1247008/answer", "answerText" : {"_value" : "
Work has taken place to ensure we have the logistical expertise, transport and workforce to roll out a vaccine according to clinical priority, at the speed at which it can be manufactured. As part of the extensive planning, the National Health Service has worked with all stakeholders, including the United Kingdom logistics industry, in order to prepare for vaccine deployment. This includes working with partners to ensure effective logistics are in place to make sure consumables, such a syringes and other supplies, are in the right place, at the right time.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4380", "label" : {"_value" : "Biography information for Jo Churchill"} } , "answeringMemberConstituency" : {"_value" : "Bury St Edmunds"} , "answeringMemberPrinted" : {"_value" : "Jo Churchill"} , "dateOfAnswer" : {"_value" : "2021-02-03", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2021-02-03T16:40:46.97Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2020-10-30", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Coronavirus: Vaccination"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what steps the Government is taking to ensure that the UK logistics industry is prepared for the mass distribution of a covid-19 vaccine; and if he will make a statement.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4064", "label" : {"_value" : "Biography information for Mr Steve Baker"} } , "tablingMemberConstituency" : {"_value" : "Wycombe"} , "tablingMemberPrinted" : [{"_value" : "Mr Steve Baker"} ], "uin" : "109318"} , {"_about" : "http://data.parliament.uk/resources/1247009", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1247009/answer", "answerText" : {"_value" : "
The Government\u2019s commitment to international collaboration is clear. We are proud to work through multilaterals such as the G7 and G20, and with the World Health Organization and international partners, including industry, to agree collaborative approaches to supporting vaccine development, manufacturing scale-up and future distribution to meet both domestic and international needs, including for the world\u2019s poorest countries.<\/p>
<\/p>
The Government continues monitors plans for the requirements across the supply chain for COVID-19 vaccines and associated material. For each vaccine that is deployed, there are clearly defined supply chain plans for manufacturing, transport, storage and distribution.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4380", "label" : {"_value" : "Biography information for Jo Churchill"} } , "answeringMemberConstituency" : {"_value" : "Bury St Edmunds"} , "answeringMemberPrinted" : {"_value" : "Jo Churchill"} , "dateOfAnswer" : {"_value" : "2021-02-03", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2021-02-03T16:50:28.377Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2020-10-30", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Coronavirus: Vaccination"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what steps the Government is taking to work with international partners to ensure that the international logistics industry and global supply chain networks are prepared for the global mass distribution of a covid-19 vaccine; and if he will make a statement.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4064", "label" : {"_value" : "Biography information for Mr Steve Baker"} } , "tablingMemberConstituency" : {"_value" : "Wycombe"} , "tablingMemberPrinted" : [{"_value" : "Mr Steve Baker"} ], "uin" : "109319"} , {"_about" : "http://data.parliament.uk/resources/1247010", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1247010/answer", "answerText" : {"_value" : "
Local test sites, such as those situated in the Watney Market Ideal store in Shadwell are deployed at the direction of Local Resilience Forums and Recovery Coordination Groups and decisions are centrally executed at their direction. This co-design approach between local and national teams has been key in achieving the pace at which these sites have been set up.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4527", "label" : {"_value" : "Biography information for Helen Whately"} } , "answeringMemberConstituency" : {"_value" : "Faversham and Mid Kent"} , "answeringMemberPrinted" : {"_value" : "Helen Whately"} , "dateOfAnswer" : {"_value" : "2020-11-25", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "previousAnswerVersion" : {"_about" : "http://data.parliament.uk/resources/1247010/answer/previousversion/58887", "answeringMember" : {"_about" : "http://data.parliament.uk/members/4527", "label" : {"_value" : "Biography information for Helen Whately"} } , "answeringMemberConstituency" : {"_value" : "Faversham and Mid Kent"} , "answeringMemberPrinted" : {"_value" : "Helen Whately"} } , "questionFirstAnswered" : [{"_value" : "2020-11-25T12:02:01.45Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2020-10-30", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Coronavirus: Screening"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the economic effect of the opening of the covid-19 testing centre situated in Watney Market Idea store in Shadwell on (a) local residents, (b) local shops and (c) Watney Market traders.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4790", "label" : {"_value" : "Biography information for Apsana Begum"} } , "tablingMemberConstituency" : {"_value" : "Poplar and Limehouse"} , "tablingMemberPrinted" : [{"_value" : "Apsana Begum"} ], "uin" : "109702"} , {"_about" : "http://data.parliament.uk/resources/1247011", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1247011/answer", "answerText" : {"_value" : "
After the end of the transition period, the United Kingdom will have autonomy over the regulation of goods, including medicines. As set out in the Northern Ireland Protocol, which will take effect on 1 January 2021, Northern Ireland will continue to follow the European Union acquis for medicines. The Government has been in intensive discussion with the European Commission on how to safeguard the crucial flows of medicines and medical products into Northern Ireland from other parts of the UK from the end of the transition period.<\/p>
The parties have agreed a pragmatic approach to implementation, including a one year time-limited approach to the application of the regulatory requirements for imports and the \u2018safety feature\u2019 elements of the Falsified Medicines Directive. This was set out in the UK Government statement of 5 November following the fourth meeting of the Ireland/Northern Ireland Specialised Committee. This approach gives industry the time and flexibility it needs and ensure that medicines can continue to flow to Northern Ireland. Further industry guidance on moving medicines to Northern Ireland after the end of the transition period will be published shortly.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4362", "label" : {"_value" : "Biography information for Edward Argar"} } , "answeringMemberConstituency" : {"_value" : "Charnwood"} , "answeringMemberPrinted" : {"_value" : "Edward Argar"} , "dateOfAnswer" : {"_value" : "2020-11-12", "_datatype" : "dateTime"} , "groupedQuestionUIN" : {"_value" : "109382"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "previousAnswerVersion" : {"_about" : "http://data.parliament.uk/resources/1247011/answer/previousversion/58863", "answeringMember" : {"_about" : "http://data.parliament.uk/members/4362", "label" : {"_value" : "Biography information for Edward Argar"} } , "answeringMemberConstituency" : {"_value" : "Charnwood"} , "answeringMemberPrinted" : {"_value" : "Edward Argar"} } , "questionFirstAnswered" : [{"_value" : "2020-11-12T13:39:22.163Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2020-10-30", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "UK Internal Trade: Northern Ireland"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what plans the Government has to maintain medical supply lines between Great Britain and Northern Ireland where EU medicine rules will still apply after the transition period.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4360", "label" : {"_value" : "Biography information for Gavin Robinson"} } , "tablingMemberConstituency" : {"_value" : "Belfast East"} , "tablingMemberPrinted" : [{"_value" : "Gavin Robinson"} ], "uin" : "109381"} , {"_about" : "http://data.parliament.uk/resources/1247012", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1247012/answer", "answerText" : {"_value" : "
After the end of the transition period, the United Kingdom will have autonomy over the regulation of goods, including medicines. As set out in the Northern Ireland Protocol, which will take effect on 1 January 2021, Northern Ireland will continue to follow the European Union acquis for medicines. The Government has been in intensive discussion with the European Commission on how to safeguard the crucial flows of medicines and medical products into Northern Ireland from other parts of the UK from the end of the transition period.<\/p>
The parties have agreed a pragmatic approach to implementation, including a one year time-limited approach to the application of the regulatory requirements for imports and the \u2018safety feature\u2019 elements of the Falsified Medicines Directive. This was set out in the UK Government statement of 5 November following the fourth meeting of the Ireland/Northern Ireland Specialised Committee. This approach gives industry the time and flexibility it needs and ensure that medicines can continue to flow to Northern Ireland. Further industry guidance on moving medicines to Northern Ireland after the end of the transition period will be published shortly.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4362", "label" : {"_value" : "Biography information for Edward Argar"} } , "answeringMemberConstituency" : {"_value" : "Charnwood"} , "answeringMemberPrinted" : {"_value" : "Edward Argar"} , "dateOfAnswer" : {"_value" : "2020-11-12", "_datatype" : "dateTime"} , "groupedQuestionUIN" : {"_value" : "109381"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "previousAnswerVersion" : {"_about" : "http://data.parliament.uk/resources/1247012/answer/previousversion/58864", "answeringMember" : {"_about" : "http://data.parliament.uk/members/4362", "label" : {"_value" : "Biography information for Edward Argar"} } , "answeringMemberConstituency" : {"_value" : "Charnwood"} , "answeringMemberPrinted" : {"_value" : "Edward Argar"} } , "questionFirstAnswered" : [{"_value" : "2020-11-12T13:39:22.23Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2020-10-30", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "UK Internal Trade: Northern Ireland"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what steps the Government is planning to take to mitigate the effect of the Border Operating Model on the supply of (a) urgent medical supplies and (b) other goods from Great Britain to Northern Ireland after the transition period.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4360", "label" : {"_value" : "Biography information for Gavin Robinson"} } , "tablingMemberConstituency" : {"_value" : "Belfast East"} , "tablingMemberPrinted" : [{"_value" : "Gavin Robinson"} ], "uin" : "109382"} , {"_about" : "http://data.parliament.uk/resources/1247013", "AnsweringBody" : [{"_value" : "Ministry of Justice"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1247013/answer", "answerText" : {"_value" : "